MM-specific universal CAR T
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 27, 2026
Universal CAR-T Cells Targeting Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=20 | Not yet recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial completion date: Dec 2026 ➔ Dec 2028 | Trial primary completion date: Sep 2026 ➔ Jul 2028
Trial completion date • Trial primary completion date • Hematological Malignancies • Multiple Myeloma • Oncology
August 23, 2023
Universal CAR-T Cells Targeting Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute
CAR T-Cell Therapy • New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 2
Of
2
Go to page
1